Suppr超能文献

流式细胞术检测 CD34+ 造血干细胞计数的三种单平台方法比较

Comparison of three single platform methods for CD34+ hematopoietic stem cell enumeration by flow cytometry.

作者信息

Marinov I, Luxova A, Tkacova V, Gasova Z, Pohlreich D, Cetkovsky P

机构信息

Institute of Hematology and Blood Transfusion, Prague, Czech Republic.

出版信息

Clin Lab. 2011;57(11-12):1031-5.

Abstract

In the present study, we compared three single platform methods for CD34+ hematopoietic stem cell (HSC) enumeration by flow cytometry. For this purpose, we analyzed the performance characteristics and results obtained from different HSC sources. Interlaboratory coefficients of variation (CV) for precision/reproducibility analysis varied from 4.0% to 6.7% / 6.7% to 9.2% for the low and 3.2% to 4.1% / 4.3% to 6.7%, respectively, for the high stem cell control. Correlation between methods ranged from 0.92% to 0.99%; Wilcoxon test showed no significant differences (p > 0.05); Bland-Altman analysis confirmed good agreement between assays (mean bias ranging from -0.48 to 6.91). Our results demonstrate very good intralaboratory correlation and agreement between methods, confirm the major impact of single platform strategy for accurate and reproducible HSC enumeration and suggest that high interlaboratory variability could be influenced by incorrect performance of validated methods.

摘要

在本研究中,我们比较了三种通过流式细胞术对CD34+造血干细胞(HSC)进行计数的单平台方法。为此,我们分析了不同HSC来源的性能特征和结果。低干细胞对照的实验室间变异系数(CV)用于精密度/重现性分析,范围为4.0%至6.7% / 6.7%至9.2%,高干细胞对照的CV分别为3.2%至4.1% / 4.3%至6.7%。方法之间的相关性范围为0.92%至0.99%;Wilcoxon检验显示无显著差异(p>0.05);Bland-Altman分析证实了各检测方法之间具有良好的一致性(平均偏差范围为-0.48至6.91)。我们的结果表明各方法之间在实验室内具有非常好的相关性和一致性,证实了单平台策略对准确和可重现的HSC计数的主要影响,并表明实验室间的高变异性可能受到已验证方法执行不当的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验